A military soldier sustained a blast injury in Afghanistan, resulting in amputations and hemipelvectomy. He developed New Delhi metallo-beta-lactamase-producing E. coli bacteremia, soft-tissue infection, and sacral osteomyelitis. These organisms are being increasingly discovered in different communities around the world. He was successfully treated with tigecycline and cefiderocol. Cefiderocol is a novel siderophore-based cephalosporine developed to treat serious infections, including those caused by carbapenem-resistant Enterobacterales.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/milmed/usab350 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!